Mary J. Kwasny

American biostatistician

Mary J. Kwasny is …
instance of (P31):
humanQ5

External links are
P2456DBLP author ID125/4056
P496ORCID iD0000-0003-3287-1903
P1153Scopus author ID14519611300

P512academic degreeDoctor of ScienceQ2248352
P166award receivedFellow of the American Statistical AssociationQ61744587
P27country of citizenshipUnited States of AmericaQ30
P69educated atHarvard UniversityQ13371
P108employerNorthwestern UniversityQ309350
Rush University Medical CenterQ1535116
P735given nameMaryQ734578
MaryQ734578
P463member ofAmerican Statistical AssociationQ467040
P106occupationuniversity teacherQ1622272
biostatisticianQ52899051
P5008on focus list of Wikimedia projectWikiProject PCC Wikidata Pilot/Northwestern University LibrariesQ104665671
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q35189254"Ictal" lateralized periodic discharges.
Q44080015"Tap and twist": preventing deep vein thrombosis in neuroscience patients through foot and ankle range-of-motion exercises.
Q31130678A randomized controlled trial evaluating a manualized TeleCoaching protocol for improving adherence to a web-based intervention for the treatment of depression
Q34585313Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population.
Q50922381Are back supports plus education more effective than education alone in promoting recovery from low back pain?: Results from a randomized clinical trial.
Q34248419Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial
Q37214187Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial
Q36761374Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study.
Q57628718Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial
Q48064519Back to the basics: regular exercise matters in parkinson's disease: results from the National Parkinson Foundation QII registry study
Q34345609Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy.
Q40746736Can the American College of Surgeons Risk Calculator Predict 30-Day Complications After Knee and Hip Arthroplasty?
Q48202388Caregiver strain in Parkinson's disease: national Parkinson Foundation Quality Initiative study
Q45996639Central obesity and high blood pressure in pediatric patients with atopic dermatitis.
Q57616705Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial
Q36809033Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States
Q92145254Clinically Meaningful Use of Mental Health Apps and its Effects on Depression: Mixed Methods Study
Q35980976Cognitively normal individuals with AD parents may be at risk for developing aging-related cortical thinning patterns characteristic of AD
Q35994007Colonic microbiome is altered in alcoholism.
Q48173702Comorbid anxiety as a differential treatment predictor for telephone versus face-to-face administered cognitive behavioral therapy for depression
Q44222749Comparing radiation toxicities across species: an examination of radiation effects in Mus musculus and Peromyscus leucopus.
Q92974789Comparison of the Effects of Coaching and Receipt of App Recommendations on Depression, Anxiety, and Engagement in the IntelliCare Platform: Factorial Randomized Controlled Trial
Q35109211Comparison of three quality of life instruments in lymphatic filariasis: DLQI, WHODAS 2.0, and LFSQQ
Q50449671Corrigendum to "The electronic medication complete communication (EMC2) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication safety in ambulatory care" [Contemp. Clin. Trials (2016) 72-77].
Q36021681Cut points on the Patient Health Questionnaire (PHQ-9) that predict response to cognitive-behavioral treatments for depression
Q53014178Cytokine responses to egg protein in previously allergic children who developed tolerance naturally.
Q45782901Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL).
Q34276903Do patients with insulin-dependent and noninsulin-dependent diabetes have different risks for complications after arthroplasty?
Q34010780Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?
Q50984035Economic burden of dermatologic adverse events induced by molecularly targeted cancer agents.
Q46192477Effect of a combined therapeutic approach of intensive lipid management, omega-3 fatty acid supplementation, and increased serum 25 (OH) vitamin D on coronary calcium scores in asymptomatic adults
Q44274416Effect of symptom-based risk stratification on the costs of managing patients with chronic rhinosinusitis symptoms
Q61415375Effectiveness of Acupressure on Pruritus and Lichenification Associated with Atopic Dermatitis: A Pilot Trial
Q34536437Efficacy of a sun protection workbook for kidney transplant recipients: a randomized controlled trial of a culturally sensitive educational intervention
Q46691221Examination of circulating folate levels as a reflection of folate intakes among older adult supplement users and nonusers in the National Health and Nutrition Examination Survey 2003-2004.
Q41534686Exploring User Learnability and Learning Performance in an App for Depression: Usability Study.
Q64066425Exploring the Use of Multiple Mental Health Apps Within a Platform: Secondary Analysis of the IntelliCare Field Trial
Q61415354Feasibility and Outcomes of a Community-Based, Pedometer-Monitored Walking Program in Chronic Stroke: A Pilot Study
Q57628721Gender Does Not Affect Postdischarge Outcomes in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan [EVEREST] Trial)
Q61415355High Incidence of Gastrointestinal Tract Disorders and Autoimmunity in Primary Cutaneous Marginal Zone B-Cell Lymphomas
Q37779693Histopathology predictors of medically refractory ulcerative colitis.
Q34248663Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial
Q37595190IntelliCare: An Eclectic, Skills-Based App Suite for the Treatment of Depression and Anxiety
Q39194226Laughter is the best medicine: The Second City® improvisation as an intervention for Parkinson's disease.
Q43490629Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
Q53629546Pain in naïve and non-naïve subjects undergoing nonablative skin tightening dermatologic procedures: a nested randomized control trial.
Q44994482Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis
Q36983784Patient reported outcomes and analgesia use in osteoarthritis of the knee.
Q40837931Perioperative Outcomes Following Unilateral Versus Bilateral Total Knee Arthroplasty
Q36157262Predictors of outcome for telephone and face-to-face administered cognitive behavioral therapy for depression
Q35527853Prompting physicians to address a daily checklist and process of care and clinical outcomes: a single-site study.
Q44846588Risk factors for the development of catheter-related bloodstream infections in patients receiving home parenteral nutrition.
Q50956525Safety of a novel microneedle device applied to facial skin: a subject- and rater-blinded, sham-controlled, randomized trial.
Q45306207Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial
Q35000892Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis.
Q41482679The Effect of BMI on 30 Day Outcomes Following Total Joint Arthroplasty
Q57628758The Impact of Chronic Obstructive Pulmonary Disease in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction: An Analysis of the EVEREST Trial
Q36341920The Relationship between Clinical, Momentary, and Sensor-based Assessment of Depression
Q64073040The Role of Data Type and Recipient in Individuals' Perspectives on Sharing Passively Collected Smartphone Data for Mental Health: Cross-Sectional Questionnaire Study
Q42744765The electronic medication complete communication (EMC2) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication safety in ambulatory care
Q37666047Therapeutic alliance in face-to-face and telephone-administered cognitive behavioral therapy
Q59660453Towards managing a platform of mental health apps: A Secondary Analysis of the IntelliCare Field Trial (Preprint)
Q35922549Trials of Intervention Principles: Evaluation Methods for Evolving Behavioral Intervention Technologies.
Q37385551Use of specialty care versus standard retail pharmacies for treatment of hepatitis C.
Q40333048Vitamin D Insufficiency and Fracture Risk in Urban Children.

Search more.